Across TCGA pan-cancer cohorts, LAMTOR3P1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of LAMTOR3P1’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where LAMTOR3P1 RNA is repressed in tumor relative to normal tissue. In most cancer types LAMTOR3P1 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

THCA, LUSC, and ESCA are the cancer types where LAMTOR3P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LAMTOR3P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	−0.039	.006	5	view →
LUSC	Male	All	+0.039	.032	2	view →
ESCA	All	All	+0.090	.026	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: LAMTOR3P1 RNA expression & survival · all LAMTOR3P1 data types